Relevant to: All Drug Manufacturers and Other Interested Parties
The purpose of this memorandum is to notify drug manufacturers that the monthly Inflation Reduction Act (IRA) technical calls will be shifting to an ad hoc schedule. Moving forward, CMS will host these calls on an ad hoc basis dependent on the calendar of implementation activities and as needed to address questions from manufacturers regarding implementation. Manufacturers will be notified of any scheduled IRA technical calls through the Health Plan Management System (HPMS) and will undergo the same registration process that has been used for these calls in the past.